drugset / Trial / NCT02539823

Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans

NCT02539823 ↗

Phase 2 Completed 45 enrolled Hurd,Yasmin, Ph.D. Jazz Pharmaceuticals · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Despite the current available therapies for opioid-dependent patients, most patients relapse. This research project focuses on the development of a novel compound, cannabidiol, to modulate opioid craving in humans based on animal models showing its selective effectiveness to inhibit drug-seeking behavior. The development of a targeted treatment for opioid relapse would be of tremendous medical and public health value.

Timeline

Start
2015-09
Primary completion
2017-05-24
Completion
2017-05-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 400 mg —
Subject Cannabidiol Other / unclassified 800 mg —

Indications